Literature DB >> 6948943

Urate-oxidase prophylaxis of uric acid-induced renal damage in childhood leukemia.

G Masera, M Jankovic, M G Zurlo, A Locasciulli, M R Rossi, C Uderzo, M Recchia.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6948943     DOI： 10.1016/s0022-3476(82)80259-x

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  7 in total

1.  Prevention and treatment of hyperuricemia with rasburicase in children with leukemia and non-Hodgkin's lymphoma.

Authors:  Imre Rényi; Edit Bárdi; Erzsébet Udvardi; Gábor Kovács; Katalin Bartyik; Pál Kajtár; Péter Masát; Kálmán Nagy; Ilona Galántai; Csongor Kiss
Journal:  Pathol Oncol Res       Date:  2007-03-27       Impact factor: 3.201

2.  One for the road! A study to assess the efficacy of single low-dose regimen of rasburicase in controlling hyperuricaemia in patients with tumour lysis syndrome due to haematological malignancies.

Authors:  Hamdy A Azim; Sherif Ahmed Bahr; Nermine Shawky Kamal; Mohamed Adel Koura; Rehab Tolba; Heba Abdelmoneem Gad; Ahmad Morsy; Hossameldin Mohsen Attia; Ibraheem Iskander; Ahmed Hammad; Mohammed Farouk Hemed; Mohammed Fathy Abdallah; Kareem Ahmed Sadek; Alaa Hamdi Taha
Journal:  Ecancermedicalscience       Date:  2013-12-10

3.  Accumulation of methotrexate polyglutamates in lymphoblasts is a determinant of antileukemic effects in vivo. A rationale for high-dose methotrexate.

Authors:  E Masson; M V Relling; T W Synold; Q Liu; J D Schuetz; J T Sandlund; C H Pui; W E Evans
Journal:  J Clin Invest       Date:  1996-01-01       Impact factor: 14.808

Review 4.  Tumor lysis syndrome: pathogenesis and management.

Authors:  D P Jones; H Mahmoud; R W Chesney
Journal:  Pediatr Nephrol       Date:  1995-04       Impact factor: 3.714

Review 5.  Difficult gout and new approaches for control of hyperuricemia in the allopurinol-allergic patient.

Authors:  A G Fam
Journal:  Curr Rheumatol Rep       Date:  2001-02       Impact factor: 4.686

6.  Pitfalls, prevention, and treatment of hyperuricemia during tumor lysis syndrome in the era of rasburicase (recombinant urate oxidase).

Authors:  Andrea Pession; Fraia Melchionda; Claudia Castellini
Journal:  Biologics       Date:  2008-03

7.  Improved cure rate in children with B-cell acute lymphoblastic leukaemia (B-ALL) and stage IV B-cell non-Hodgkin's lymphoma (B-NHL)--results of the UKCCSG 9003 protocol.

Authors:  A Atra; M Gerrard; R Hobson; J D Imeson; S Ashley; C R Pinkerton
Journal:  Br J Cancer       Date:  1998-06       Impact factor: 7.640
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.